Literature DB >> 18444229

A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort.

Patrick Taffé1, Margaret May.   

Abstract

In studies of the natural history of HIV-1 infection, the time scale of primary interest is the time since infection. Unfortunately, this time is very often unknown for HIV infection and using the follow-up time instead of the time since infection is likely to provide biased results because of onset confounding. Laboratory markers such as the CD4 T-cell count carry important information concerning disease progression and can be used to predict the unknown date of infection. Previous work on this topic has made use of only one CD4 measurement or based the imputation on incident patients only. However, because of considerable intrinsic variability in CD4 levels and because incident cases are different from prevalent cases, back calculation based on only one CD4 determination per person or on characteristics of the incident sub-cohort may provide unreliable results. Therefore, we propose a methodology based on the repeated individual CD4 T-cells marker measurements that use both incident and prevalent cases to impute the unknown date of infection. Our approach uses joint modelling of the time since infection, the CD4 time path and the drop-out process. This methodology has been applied to estimate the CD4 slope and impute the unknown date of infection in HIV patients from the Swiss HIV Cohort Study. A procedure based on the comparison of different slope estimates is proposed to assess the goodness of fit of the imputation. Results of simulation studies indicated that the imputation procedure worked well, despite the intrinsic high volatility of the CD4 marker.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444229     DOI: 10.1002/sim.3294

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  21 in total

1.  Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.

Authors:  Satish K Pillai; Mohamed Abdel-Mohsen; John Guatelli; Mark Skasko; Alexander Monto; Katsuya Fujimoto; Steven Yukl; Warner C Greene; Helen Kovari; Andri Rauch; Jacques Fellay; Manuel Battegay; Bernard Hirschel; Andrea Witteck; Enos Bernasconi; Bruno Ledergerber; Huldrych F Günthard; Joseph K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  Determinants of HIV-1 broadly neutralizing antibody induction.

Authors:  Peter Rusert; Roger D Kouyos; Claus Kadelka; Hanna Ebner; Merle Schanz; Michael Huber; Dominique L Braun; Nathanael Hozé; Alexandra Scherrer; Carsten Magnus; Jacqueline Weber; Therese Uhr; Valentina Cippa; Christian W Thorball; Herbert Kuster; Matthias Cavassini; Enos Bernasconi; Matthias Hoffmann; Alexandra Calmy; Manuel Battegay; Andri Rauch; Sabine Yerly; Vincent Aubert; Thomas Klimkait; Jürg Böni; Jacques Fellay; Roland R Regoes; Huldrych F Günthard; Alexandra Trkola
Journal:  Nat Med       Date:  2016-09-26       Impact factor: 53.440

3.  Correcting for exposure misclassification using survival analysis with a time-varying exposure.

Authors:  Katherine Ahrens; Timothy L Lash; Carol Louik; Allen A Mitchell; Martha M Werler
Journal:  Ann Epidemiol       Date:  2012-10-05       Impact factor: 3.797

4.  CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland.

Authors:  Margaret May; Robin Wood; Landon Myer; Patrick Taffé; Andri Rauch; Manuel Battegay; Matthias Egger
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

5.  A Bayesian hierarchical model with novel prior specifications for estimating HIV testing rates.

Authors:  Qian An; Jian Kang; Ruiguang Song; H Irene Hall
Journal:  Stat Med       Date:  2015-11-15       Impact factor: 2.373

6.  Bayesian reconstruction of transmission trees from genetic sequences and uncertain infection times.

Authors:  Hesam Montazeri; Susan Little; Mozhgan Mozaffarilegha; Niko Beerenwinkel; Victor DeGruttola
Journal:  Stat Appl Genet Mol Biol       Date:  2020-10-21

7.  Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.

Authors:  Thierry Buclin; Amalio Telenti; Rafael Perera; Chantal Csajka; Hansjakob Furrer; Jeffrey K Aronson; Paul P Glasziou
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

8.  Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.

Authors:  Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Philip Rieder; Beda Joos; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Andri Rauch; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; Bruno Ledergerber; Sebastian Bonhoeffer; Huldrych F Günthard
Journal:  Clin Infect Dis       Date:  2011-01-10       Impact factor: 9.079

9.  A Systematic Review and Meta-analysis to Estimate the Time from HIV Infection to Diagnosis for People with HIV.

Authors:  Semiu O Gbadamosi; Mary Jo Trepka; Rahel Dawit; Rime Jebai; Diana M Sheehan
Journal:  AIDS Rev       Date:  2022-03-01       Impact factor: 2.500

10.  Is back-projection methodology still relevant for estimating HIV incidence from national surveillance data?

Authors:  Kylie-Ann Mallitt; David P Wilson; Ann McDonald; Handan Wand
Journal:  Open AIDS J       Date:  2012-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.